Bill Search

  • Introduced
    May 25, 2021
  • Passed Senate
    Apr 07, 2022
  • Passed House
    Apr 07, 2022
  • Signed into Law
LD 1729
Maine Senate Bill
Did you know we offer free bill tracking in Congress and 50 states, and a great mobile app? Sign up here
SP 574, Resolve, To Assess The Feasibility Of The Production Of Insulin In Maine
Last Action See all actions
Senate • Apr 11, 2022: FINALLY PASSED, in concurrence.

Official Summary/Bill Text

Comments on LD 1729

Tweets

Whip Lists

Sponsors
Votes
Looks like there aren't any voting records available at this moment.
Actions
  • Apr 11, 2022 | Senate
    • FINALLY PASSED, in concurrence.
  • Apr 07, 2022 | House
    • CONSENT CALENDAR - FIRST DAY
    • Under suspension of the rules CONSENT CALENDAR - SECOND DAY.
    • The Resolve was PASSED TO BE ENGROSSED as Amended by Committee Amendment "A" (S-508).
    • In concurrence. ORDERED SENT FORTHWITH.
    • FINALLY PASSED.
    • Sent for concurrence. ORDERED SENT FORTHWITH.
  • Apr 07, 2022 | Senate
    • Report READ and ACCEPTED.
    • READ ONCE.
    • Committee Amendment "A" (S-508) READ and ADOPTED.
    • Under suspension of the Rules, READ A SECOND TIME and PASSED TO BE ENGROSSED AS AMENDED BY Committee Amendment "A" (S-508).
    • Ordered sent down forthwith for concurrence.
  • Jul 19, 2021 | Senate
    • CARRIED OVER, in the same posture, to any special or regular session of the 130th Legislature, pursuant to Joint Order HP 1302
  • May 25, 2021 | Senate
    • Received by the Secretary of the Senate on May 25, 2021 and REFERRED to the Committee on HEALTH AND HUMAN SERVICES pursuant to Joint Rule 308.2